Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -64.88 is 134% below its 4-year average of -27.68, near the low end of its 4-year range (-64.88–-6.09).
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -16.65.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
EARNINGS PER SHARE (EPS)
-64.88
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-29.14
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-122.65%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Scilex Holding Company
Market Cap
$32.35M
Earnings Per Share (EPS)
-64.88
TTM Avg
N/A
3Y Avg
-29.14
5Y Avg
N/A
Market Cap
$32.68M
Earnings Per Share (EPS)
-1.39
TTM Avg
-0.88
3Y Avg
-6.06
5Y Avg
-17.91
Market Cap
$33.66M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.68
3Y Avg
-0.92
5Y Avg
-0.73
Market Cap
$33.54M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
Market Cap
$31.44M
Earnings Per Share (EPS)
0.37
TTM Avg
-0.28
3Y Avg
0.68
5Y Avg
0.80
Market Cap
$33.55M
Earnings Per Share (EPS)
-0.40
TTM Avg
-0.21
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$34.04M
Earnings Per Share (EPS)
0.94
TTM Avg
-0.29
3Y Avg
-1.25
5Y Avg
-1.59
Market Cap
$34.50M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
Market Cap
$30.85M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $32.35M | -64.88 | N/A | -29.14 | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $32.68M | -1.39 | -0.88 | -6.06 | -17.91 |
| HeartBeam, Inc. (BEAT)vs › | $33.66M | -0.52 | -0.68 | -0.92 | -0.73 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.54M | -7.30 | -11.70 | -7.29 | -5.93 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 0.37 | -0.28 | 0.68 | 0.80 |
| Accuray Incorporated (ARAY)vs › | $33.55M | -0.40 | -0.21 | -0.17 | -0.13 |
| Elutia Inc (ELUT)vs › | $34.04M | 0.94 | -0.29 | -1.25 | -1.59 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | -1.26 | -0.80 | -2.79 | -3.86 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | N/A | -0.24 | -0.01 | 0.39 |
| MDxHealth S.A. (MDXH)vs › | $30.83M | N/A | -0.73 | -1.47 | -1.95 |
Trailing EPS (TTM)
$-64.88
Forward EPS (Est.)
$-0.55
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -36.48 |
| 2023-12-31 | -44.85 |
| 2022-12-31 | -6.09 |
| 2021-12-31 | -23.29 |
